With quality improvements come competitive advantages - 8th Annual Quality & OPEX in Pharma & Biotech Conference
FRANKFURT, June 5, 2012 – Improving quality in pharma manufacturing means not only reducing production costs but also regulatory risks, therefore providing a competitive advantage. Nowadays the majority of pharmaceutical companies consider serious compliance issues an incentive to take further steps towards quality optimization
How successful are you in taking proactive approaches to managing quality risks & facilitating continual improvement in operational excellence?
Do you ask how to engage all employees effectively in the improvement work?
Following seven successful events, Fleming Europe is coming to Germany this year to answer all your questions and provide concrete solutions to overcome the challenges lying ahead for the pharma industry.
8th Annual Quality & OPEX in Pharma & Biotech
4 – 5 October 2012, Frankfurt
Leading pharma players such as Pfizer, Roche, Sanofi, Merck, Novartis, Genzyme, Teva, etc. understand that manufacturing quality is becoming a key driver in successful and timely product launches, optimizing revenue streams, enhancing the company's reputation and maximizing shareholder value.
Besides the industry insight into the best practice approaches in achieving quality compliance, Fleming Europe has speakers from competent inspecting authorities on board – former FDA GMP expert, inspector from Hannover inspectorate, and former head of AFSSAPS, etc. They will share their specific experiences, present their findings and reveal the most common and reoccurring deficiencies during inspections and audits.
During the 2-day conference, all attendees will have the opportunity to take advantage from many special features. Exclusive insight outside the pharma industry, two special streams during both days, an interactive workshop, and practical case studies will provide insight into the most pressing issues.
How to link quality to performance & business strategy • Achieving quality – operational excellence synergies • Quality risk management tools & techniques • Managing change & transformation in manufacturing & across the entire organization • Compliance & operational efficiencies through a robust CAPA system • Quality assurance in contract manufacturing • Achieving process improvements in pharma & biotech through QbD & PAT, six sigma, and Kaizen approach
Who should attend this event?
Senior Vice Presidents, Vice Presidents, Senior Executives, Heads, Directors, Managers of Quality Management, Quality Assurance, Quality Operations, Quality Control, Quality Systems, Regulatory Affairs, GMP Compliance, OpEx, Business Process Excellence, Innovation, PAT, Lean/Six Sigma, Lean Manufacturing, API manufacturing, Technical operations, Contract Manufacturing, Operational Excellence, Operations, Production, Manufacturing, Supply Chain.
About Fleming Europe
Established in Slovakia, Fleming Europe represents a Pan-European B2B networking channel for specialists to collect & share knowledge. Since 2004, the company has been encouraging decision makers to share their experiences through market leading conferences, trainings and webinars. The annual audience of 10,000 Banking, Defense, Energy, Oil & Gas, Pharma, Telco and Transport peers benefit from insights on industry trends when applying them to their own business practices.
For more information visit www.flemingeurope.com
# # #
Andrea Weber
Marketing Manager
Fleming Europe
Bratislava, Slovak Republic
Tel: +421 257 272 335
Fax: +421 255 644 490
andrea.weber@flemingeurope.com
www.flemingeurope.com
